Human studies indicate that galacto-oligosaccharides (GOS)/FOS can reduce significantly the plasma level of total IgE and IgG1, IgG2, and IgG3 in infants at risk for allergy (Van et al., 2010). Here, IGHE is linked to allergic disease.